ArticleOncotarget2017

The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1.

Youngmi Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.